Goodwin Procter advised Wave Life Sciences on the deal. Wave Life Sciences (Nasdaq: WVE) announced its strategic collaboration with GSK (LSE/NYSE: GSK) to advance oligonucleotide therapeutics, including...
This content is for Standard 1 Year members only. LoginJoin Now